Skip to content
stoqly

Gentex

GNTX Nasdaq Automotive Parts & Equipment Financials FY2016–FY2025

Gentex's revenue rose 9.6% to $2.5 billion in fiscal 2025. Its operating margin was 18.7%, down from 19.9% a year earlier. Free cash flow was $458 million, up 29.6%. It paid out $422 million in dividends and buybacks, 92% of free cash flow. The diluted share count fell 3.6%.

Last close · Oct 23, 2026

$20.66

5.0%
Value it Compare
Revenue Total sales reported in the income statement.
$2.5B
9.6% vs prior year
Operating margin Operating income as a share of revenue.
18.7%
1.2 pts
Net income Profit after all expenses, interest and tax.
$385M
4.9%
Free cash flow Cash from operations minus capital spending.
$458M
29.6%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
17.4%
1.0 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$4.3B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
10.9x
On $1.89 EPS (TTM)

What Gentex does

No business description yet.

Legal name
GENTEX CORPORATION
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0000355811-26-000010
0000355811

Revenue and margins

Gentex had $2.5B of revenue in fiscal 2025, up 9.6% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 4.3% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $458M in fiscal 2025, 18.1% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Gentex returned $422M to shareholders in fiscal 2025, 92% of free cash flow. The diluted share count fell 3.6%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Gentex yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of $147M and divides by 217.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 10.9x · peers 16.6x · sector 17.9x.

Balance sheet

Cash, debt and the ratios that show how comfortably Gentex can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $268M$238M$241M$256M$151M
Debt incl. finance leases $0.0M$0.0M$0.0M$0.0M$3.8M
Net debt / EBITDA −0.5x−0.5x−0.4x−0.5x−0.3x
Debt / equity 0.0x0.0x0.0x0.0x0.0x
Current ratio 4.8x3.8x3.7x4.1x2.9x
Quick ratio 3.1x2.2x2.2x2.4x1.6x
Total assets $2.1B$2.3B$2.6B$2.8B$2.9B
Total liabilities $193M$261M$299M$289M$438M
Shareholders' equity $1.9B$2.1B$2.3B$2.5B$2.5B
Net debt (− = net cash) −$268M−$238M−$241M−$256M−$147M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$2.7M

8 insiders

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
May 15, 2026 Brian C WalkerDirector Sold 5,939 $22.98 $0.1M Form 4
May 5, 2026 Leslie L BrownDirector Sold 10,782 $22.85 $0.2M Form 4
Apr 30, 2026 Richard O SchaumDirector Sold 4,815 $23.31 $0.1M Form 4
Feb 17, 2026 Kevin C NashChief Financial Officer Sold 11,885 $24.98 $0.3M Form 4
Feb 17, 2026 Matthew ChiodoVice President of Sales Sold 19,827 $25.03 $0.5M Form 4
Feb 17, 2026 Neil BoehmChief Technology Officer Sold 11,248 $24.82 $0.3M Form 4
Feb 17, 2026 Scott P RyanGeneral Counsel Sold 9,024 $24.73 $0.2M Form 4
Feb 17, 2026 Steven R DowningPresident and CEO Sold 35,000 $24.75 $0.9M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✓ ✕ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✕ ✕ ✕
Current ratio rose ✕ ✓ ✕
Share count didn't rise ✓ ✓ ✓
Gross margin rose ✓ ✓ ✓
Revenue rose relative to assets ✓ ✕ ✓
F-score 7 / 96 / 96 / 9
Accruals ratio −4.4%−3.5%−7.1%
Altman Z'' 12.8913.6910.35

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Gentex GNTX $4.3B 9.6% 18.7% 18.1% 17.4% 10.9x 6
Dorman Products DORM $3.8B 6.0% 14.1% 3.6% 12.4% 17.4x 8 Compare →
Mobileye MBLY $5.3B 14.5% −23.2% 27.6% — — — Compare →
Standard Motor Products SMP $853M 22.4% 7.6% 1.0% 8.3% 16.6x 7 Compare →
Visteon VC $2.0B −2.5% — — 19.3% 13.2x 7 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $1.7B $1.8B $1.8B $1.9B $1.7B $1.7B $1.9B $2.3B $2.3B $2.5B
Gross profit $669M $695M $691M $688M $605M $620M $610M $763M $771M $867M
Research and development $94.2M $99.7M $107M $115M $116M $118M $133M $154M $182M $203M
Operating income $512M $523M $508M $489M $400M $410M $370M $496M $460M $474M
Interest expense — $3.0M $0.8M — — — — — — —
Pretax income $511M $532M $522M $500M $412M $416M $370M $505M $472M $461M
Income tax $163M $125M $84.2M $75.7M $64.2M $55.6M $51.0M $76.6M $67.7M $76.4M
Net income $348M $407M $438M $425M $348M $361M $319M $428M $405M $385M
Diluted EPS $1.19 $1.41 $1.62 $1.66 $1.41 $1.50 $1.36 $1.84 $1.76 $1.74
Diluted shares 0.29B 0.29B 0.27B 0.25B 0.24B 0.24B 0.23B 0.23B 0.23B 0.22B
Cash flow
Cash from operations $477M $501M $552M $506M $465M $362M $338M $537M $498M $587M
Capital expenditure $121M $104M $86.0M $84.6M $51.7M $68.8M $146M $184M $145M $129M
Free cash flow $356M $397M $466M $421M $413M $293M $192M $354M $354M $458M
Depreciation and amortization $88.6M $99.6M $102M $105M $105M $99.1M $96.6M $93.3M $94.7M $104M
Stock-based compensation $19.2M $18.4M $18.3M $21.7M $30.8M $27.4M $30.2M $39.2M $39.5M $36.6M
Acquisitions $0.0M $0.0M $0.0M $0.0M $11.2M $12.1M $0.0M $18.9M $2.9M $156M
Share buybacks $163M $231M $592M $332M $289M $325M $113M $147M $206M $316M
Dividends paid $101M $109M $117M $116M $117M $115M $113M $112M $110M $107M
Dividends and buybacks $264M $340M $708M $448M $406M $440M $226M $260M $317M $422M
Balance sheet
Cash and short-term investments $724M $722M $386M $437M $451M $268M $238M $241M $256M $151M
Total debt $178M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $3.8M
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $1.2B $1.2B $851M $950M $979M $873M $949M $998M $1.0B $1.1B
Current liabilities $150M $244M $169M $172M $178M $182M $251M $272M $253M $388M
Inventory $189M $217M $225M $249M $226M $316M $404M $403M $437M $516M
Property and equipment, net $466M $493M $499M $498M $468M $464M $550M $653M $729M $791M
Total assets $2.3B $2.4B $2.1B $2.2B $2.2B $2.1B $2.3B $2.6B $2.8B $2.9B
Total liabilities $399M $303M $224M $231M $234M $193M $261M $299M $289M $438M
Shareholders' equity $1.9B $2.0B $1.9B $1.9B $2.0B $1.9B $2.1B $2.3B $2.5B $2.5B
Margins
Gross margin 39.8% 38.7% 37.7% 37.0% 35.9% 35.8% 31.8% 33.2% 33.3% 34.2%
Operating margin 30.5% 29.2% 27.7% 26.3% 23.7% 23.7% 19.3% 21.6% 19.9% 18.7%
EBITDA margin 35.8% 34.7% 33.3% 31.9% 29.9% 29.4% 24.3% 25.6% 24.0% 22.8%
Net margin 20.7% 22.7% 23.9% 22.9% 20.6% 20.8% 16.6% 18.6% 17.5% 15.2%
FCF margin 21.2% 22.1% 25.4% 22.7% 24.5% 16.9% 10.0% 15.4% 15.3% 18.1%
Returns
Return on capital 25.3% 29.7% 30.4% 27.9% 22.4% 22.3% 18.2% 21.6% 18.4% 17.4%
Return on capital employed 24.5% 24.5% 25.3% 25.0% 19.9% 20.6% 18.4% 22.5% 19.0% 18.8%
Return on equity 19.1% 20.6% 22.4% 22.4% 17.8% 18.5% 15.9% 19.6% 16.9% 15.5%
Return on assets 15.6% 17.5% 19.7% 20.0% 15.9% 16.7% 14.3% 17.4% 15.1% 13.5%
Growth
Revenue growth 8.8% 6.9% 2.2% 1.4% −9.2% 2.6% 10.9% 19.8% 0.6% 9.6%
Net income growth 9.1% 17.0% 7.6% −3.0% −18.2% 3.8% −11.7% 34.4% −5.6% −4.9%
EPS growth 10.2% 18.5% 14.9% 2.5% −15.1% 6.4% −9.3% 35.3% −4.4% −1.1%
FCF growth 38.8% 11.5% 17.5% −9.7% −2.0% −28.9% −34.6% 84.4% −0.0% 29.6%
Share count change −1.7% −1.0% −6.4% −6.2% −3.8% −2.9% −2.3% −0.7% −1.6% −3.6%
Financial health
Net debt / EBITDA −0.9x −1.2x −0.6x −0.7x −0.9x −0.5x −0.5x −0.4x −0.5x −0.3x
Debt / equity 0.1x 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x 0.0x
Interest coverage — 174.5x 635.2x — — — — — — —
Current ratio 7.7x 4.9x 5.0x 5.5x 5.5x 4.8x 3.8x 3.7x 4.1x 2.9x
Quick ratio 6.4x 4.0x 3.7x 4.1x 4.2x 3.1x 2.2x 2.2x 2.4x 1.6x
Capital allocation
Capex / revenue 7.2% 5.8% 4.7% 4.6% 3.1% 4.0% 7.6% 8.0% 6.3% 5.1%
Stock comp / revenue 1.1% 1.0% 1.0% 1.2% 1.8% 1.6% 1.6% 1.7% 1.7% 1.5%
Payouts / FCF 74.3% 85.7% 151.8% 106.3% 98.3% 150.0% 117.7% 73.4% 89.5% 92.2%
Quality scores
Piotroski F-score 9.0 6.0 7.0 7.0 4.0 6.0 5.0 7.0 6.0 6.0
Altman Z'' 11.1 13.0 14.2 14.4 14.0 15.5 12.9 12.9 13.7 10.4
Accruals ratio −5.8% −4.0% −5.2% −3.8% −5.4% −0.1% −0.9% −4.4% −3.5% −7.1%

Source: SEC EDGAR XBRL filings (CIK 0000355811). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open